Drugs and placebos: What's the difference?: Understanding the molecular basis of the placebo effect could help clinicians to better use it in clinical practice

EMBO Reports

Volumn 15, Issue 4, 2014, Pages 329-332

  Benedetti, Fabrizio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; DRUG EFFECT; DRUG RESEARCH; DRUG SCREENING; HUMAN; PLACEBO EFFECT; PRIORITY JOURNAL; CULTURAL ANTHROPOLOGY; PATIENT CARE; PSYCHOLOGY;

CULTURE; HUMANS; PATIENT CARE; PLACEBO EFFECT;

EID: 84898631488     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1002/embr.201338399     Document Type: Article

References (10)

1. Wager TD, Scott DJ, Zubieta JK, (2007) Placebo effects on human (micro)-opioid activity during pain. Proc Natl Acad Sci USA 104: 11056-11061 (Pubitemid 47175225)
2. Benedetti F, Amanzio M, Rosato R, Blanchard C, (2011) Non-opioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 17: 1228-1230
3. Benedetti F, Amanzio M, Thoen W, (2011) Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology 213: 791-797
4. de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ, (2001) Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293: 1164-1166 (Pubitemid 32758101)
5. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B, Lopiano L, (2004) Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 7: 587-588 (Pubitemid 38691896)
6. Vase L, Robinson ME, Verne GN, Price DD, (2003) The contributions of suggestion, expectancy and desire to placebo effect in irritable bowel syndrome patients. Pain 105: 17-25 (Pubitemid 37162469)
7. Benedetti F, Amanzio M, Vighetti S, Asteggiano G, (2006) The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 26: 12014-12022 (Pubitemid 44772112)
8. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK, (2008) Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 65: 220-231 (Pubitemid 351214321)
9. Benedetti F, Pollo A, Colloca L, (2007) Opioid-mediated placebo responses boost pain endurance and physical performance-Is it doping in sport competitions? J Neurosci 27: 11934-11939 (Pubitemid 350072084)
10. Atlas LY, Whittington RA, Lindquist MA, Wielgosz J, Sonty N, Wager TD, (2012) Dissociable effects of opiates and expectations on pain. J Neurosci 32: 8053-8064